“…Human amniotic membrane was previously treated with 1 percent Trypsin/EDTA, which eliminated epithelial and mesenchymal cells while keeping the basal membrane and extracellular matrix intact. The latter was mechanically powerful, had anti-inflammatory, anti-microbial, anti-fibrotic, anti-scarring, and biocompatibility properties, but had only a minor immunogenicity ( Rieder et al, 2004 ; Young et al, 2005 ; Baguneid et al, 2006 ; Bhatia et al, 2007 ; Lim et al, 2009 ; Peter Crapo et al, 2011 ; Caruso et al, 2013 ; Mamede et al, 2015 ; Sanluis-Verdes et al, 2015 ; Zhang et al, 2016 ). The protection of essential molecules such as anti-inflammatory cytokines, growth factors, and extracellular matrix factors, as well as the structural integrity of the non-cellular matrix, should be the focus of future advances in the processing and stabilization of HAM for wound dressing.…”